![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0034.png)
34
14.
Farhi D, Dupin N, Palangié A, Carlotti A, Avril
MF. Incomplete excision of basal cell
carcinoma:rateand associated factors among
362
consecutives
cases.
Dermat
Surg
2007;33:1207-14.
15.
Kimyai-Asadi A, Katz T, Goldberg LH, Ayala
GB, Wang SB, Vujevich JJ, et al. Margin
involvement after the excision of melanoma in
situ: the need for complete en face examination
of the surgical margins. Dermatol Surg
2007;33:1434-9.
16.
Julian CG, Bowers PW. A prospective study of
Mohs’ micrographic surgery in two English
Centres. Br J Dermatol 1997;136:515-18.
17.
Sahai S, Walling HW. Factors predictive of
complex Mohs Surgery cases. J Dermatolog
Treat 2012;23:421-7
18.
Malhotra R, Huilgol SC, Huynh NT, Selva D.
The Australian Mohs, database, part II:
periocular basal cell carcinoma outcome at 5-
year follow-up. Opthalmology 2004;111:631-6.
19.
Leibovitch I, Huilgol SC, Selva D, Hill D,
Richards S, Paver R.
Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.J Am Acad Dermatol 2005;53:253-60.
20.
Pugliano-Mauro M, Goldman G.Mohs
surgery is effective for high-risk
cutaneous